Autres langues SynAct Pharma AB

Actions

SYNACT

SE0008241491

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:51 21/05/2024			Varia. 5j.	Varia. 1 janv.
7,195 ^SEK	+2,86%		+4,50%	-18,52%

23/04	Synact Pharma AB annonce des changements au sein du comité de nomination en vue de l'assemblée générale de 2024	CI
20/03	Le suédois SynAct Pharma nomme un nouveau PDG	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioStock: SynAct Pharma's CEO provides an update	02/05
Change in number of shares and votes in SynAct Pharma AB	30/04
Notice of annual general meeting in SynAct Pharma AB	30/04
Bulletin from the extraordinary general meeting of SynAct Pharma AB	24/04
SynAct Pharma : Changes in SynAct Pharma's Nomination Committee ahead of the 2024 Annual General Meeting	23/04
Changes in SynAct Pharma’s Nomination Committee ahead of the 2024 Annual General Meeting	23/04
Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting	23/04
BioStock: Synact focuses on pushing forward rheumatoid arthritis project	02/04
Notice of extraordinary general meeting in SynAct Pharma AB	27/03
SynAct Pharma : has successfully completed the bookbuilding procedure - directed issues provide the company with a total of up to 49.2 MSEK.	27/03
SynAct Pharma AB announces intention to carry out directed share issues in total of approximately 48 MSEK	26/03
SynAct Pharma publishes Annual Report 2023	26/03
SynAct Pharma AB (publ) ("SynAct") brings forward the publication of the annual report.	25/03
SynAct Pharma comments on ownership changes among senior executives	22/03
Synact's new CEO to BioStock: "I'm hitting the ground running"	22/03
Sweden's SynAct Pharma Names New CEO	20/03
SynAct Pharma appoints Jeppe Øvlesen CEO	20/03
SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting	20/03
SynAct Pharma AB Announces CEO Changes	20/03
Bulletin from the extraordinary general meeting of SynAct Pharma AB	20/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SynAct Pharma AB

Actions

SYNACT

SE0008241491

Autres langues

Filtres